Patents by Inventor Thomas D. Dschietzig

Thomas D. Dschietzig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170182127
    Abstract: A pharmaceutical composition for treatment of persons afflicted of heart failure with preserved ejection fraction (HFPEF), diastolic heart failure (DHF) or diastolic dysfunction (DF), the composition comprising a therapeutically effective amount of a compound capable of specific binding to the relaxin receptor (RXFP1) present on fibroblasts, fibromyoblasts, endothelial cells, endocardial cells, and cardiomyocytes in the cardiac muscle to increase the heart's stroke volume at lower end-diastolic pressure.
    Type: Application
    Filed: May 26, 2015
    Publication date: June 29, 2017
    Applicant: Relaxera Pharmazeutische Gesellschaft mbH & Co. KG
    Inventor: Thomas D. Dschietzig